GSK Consumer Healthcare Ltd
|
|
- Sylvia Barrett
- 6 years ago
- Views:
Transcription
1 GICS Industry : Food Products l Sub Industry : Packaged foods & meats l Website : GSK Consumer Healthcare Ltd Key Stock Indicators NSE Ticker : GSKCONS Bloomberg Ticker : SKB:IN Face value / Share: 1. Div. Yield (%):.9 CMP (as on 28 Jan 211 Rs/Share) weekrange up to 28 Jan 211 (Rs)(H/L): 239.1/ Market Cap as on 28 Jan 211 (Rs Mn): 8,14 Enterprise Value as on 28 Jan 211 (Rs Mn): 76,96 Shares outstanding (mn): 42.1 Free Float (%): 6.8 Average daily volumes (12 months) : 17,98 Beta (2 year) :.6 GlaxoSmithKline Consumer Healthcare (GSKCH) is an associate of GlaxoSmithKline Plc (UK). The parent company was formed in 2, following the merger between GlaxoWellcome and SmithKline Beecham. GSKCH s product portfolio consists of nutritional products such as Horlicks, Boost and Maltova, and also drugs such as rubefacients (Iodex) and gastrointestinal/ analgesics such as Crocin and Eno. KEY HIGHLIGHTS Product portfolio has strong brands GSKCH s product portfolio consists of nutritional brands such as Horlicks, Boost and Maltova, while it has rubefacients like Iodex and gastrointestinal/ analgesics brands like Crocin and Eno. Horlicks is a well-know brand in the white segment of the health food drinks industry and contributes significantly to its market share there. Extension of product line The company s R&D function has fostered the development of new products through innovation. Products introduced in 29 include Glaxo Nutrition's ActiGrow, Horlicks Nutribar, Junior Horlicks, biscuits, Asha from Horlicks, Horlicks Cornflake Crunchies Biscuits, Foodles from Horlicks and Horlicks Proheight. GSKCH is a part of GlaxoSmithKline Plc of the UK, which has a 27% market share in the global pharmaceutical market. Exports drive growth The Company exports products to Bangladesh, Myanmar, Sri Lanka, Malaysia, to the Middle East and other markets. Efforts are also being made to target markets in Southeast Asia. Exports registered a CAGR of 36.17% from CY6 to CY9. Exports contributed ~8% of the total revenue CY9. Key Financial Indicators Dec-7 Dec-8 Dec-9 Revenue (Rs mn) 13, , ,8.7 EBITDA margins (%) PAT (Rs mn) 1, , ,327.8 PAT margins(%) Gearing (x) EPS (Rs/share) PE (x) P/BV (x) RoCE (%) RoE (%) EV/EBITDA (x) n.m. : Not meaningful 2.6 Shareholding (As on September 3, 21) FII 11% DII 19% Others 27% KEY RISKS Expiry of drug patents Drug price control order (DPCO) imposed by Government of India Stock Performances vis-à-vis market Indexed price chart Promoter 43% Returns (%) YTD 1-m 3-m 12-m GSKCONS NIFTY Note: 1) YTD returns are since Jan 4, 21 to Jan 28, ) 1-m, 3-m and 12-m returns are up to Jan 28, 211. (index) Jan-1 Feb-1 Mar-1 Apr-1 May-1 Jun-1 Jul-1 Aug-1 Sep-1 Oct-1 Nov-1 Dec-1 (') Volumes (RHS) GSKCONS NIFTY CRISIL COMPANY REPORT 1
2 BACKGROUND GSKCH is the Indian associate of GlaxoSmithKline Plc (UK). Its product portfolio consists of nutritional products such as Horlicks, Boost and Maltova, while on the pharma side, it has rubefacients like Iodex and gastrointestinal/ analgesics like Crocin and Eno. The company has manufacturing facilities at Nabha in Punjab, Rajahmundry in Andhra Pradesh and Sonepat in Haryana. It has an established distribution network in India. GSKCH exports to Bangladesh, Myanmar, Sri Lanka, Malaysia, and the Middle East. Exports contributed ~8% of total revenue for CY9. The company s R&D division has helped develop new products, including 29 s launches such as Glaxo Nutrition's ActiGrow, Horlicks Nutribar etc. COMPETITIVE POSITION Peer Comparison GlaxoSmithKline Consumer Healthcare Ltd Nestle India Ltd REI Agro Ltd annia Industries Ltd Dec-9 Dec-9 Mar-1 Mar-1 Revenue (Rs mn) 19,8.7 1,23. 36, ,871.9 EBITDA margins (% PAT (Rs mn) 2, ,. 1,71.7 1,33.2 PAT margins(%) Gearing (x) EPS (Rs/share) PE (x) P/BV (x) RoCE (%) RoE (%) EV/EBITDA (x) n.m: Not meaningful FINANCIAL PROFILE Top-line and PAT grow in FY1, operating margin stays flat The company s top-line grew 22.8% CAGR from CY7 to CY9 on the back of price increases and volume growth. EBITDA margin remained flat as costs rose in proportion to increase in revenues. PAT increased by 23.6 % in CY9 to Rs 2.3 bn, helped by reduction in operating expenses as a result of efficient operations. Key Financial Indicators Units Dec-7 Dec-8 Dec-9 Revenue Rs million 13, , ,8.7 EBITDA margins PAT Rs million 1, , ,327.8 PAT margins Revenue growth EBITDA growth PAT growth Gearing Times... RoCE RoE CRISIL COMPANY REPORT 2
3 INDUSTRY PROFILE Pharmaceuticals Over the past five years, the Indian pharmaceutical industry grew at a CAGR of about per cent and reached a market size of about $21.4 billion in The industry is dominated by exports which are estimated to have contributed about 6 per cent to the industry in The strong growth in the Indian pharmaceuticals industry has been primarily driven by exports of formulations and bulk drugs while the domestic formulations market has maintained its steady growth. Between 24- and 29-1, formulation exports have surged at a CAGR of -27 per cent owing to the opening-up of a huge generic opportunity in regulated market while demand from the semi-regulated market remained robust. In the domestic market, the emergence of lifestyle segments such as anti-diabetic, cardiovascular and gastrointestinal have been chief growth (12-14 per cent) drivers over the last 4- years. Bulk drug exports have grown at a compounded rate of 34-3 per cent over the last five years to an estimated $7. billion in Indian companies have the advantage of lower costs and well-developed process chemistry skills (employee and manufacturing costs) as compared to companies in US and Europe. Indian players are increasingly focusing on exports to generic players and innovators in regulated markets. Branded Foods The branded foods industry includes units manufacturing bakery products, dairy and milk products, confectioneries and ready-to-eat products. While India ranks among the largest food producers in the world, its share in the processed food industry is miniscule, reflecting the low penetration levels and inadequate supply chain infrastructure. India, however, has an abundant supply of the raw materials as it is one of the world`s largest producers of milk, food grains, fruits, vegetables, spices, sugar and oilseeds. Demand growth in the branded foods industry depends on the ability of manufacturers to offer a wide range of products that meet regional tastes at competitive prices. Increase in the level of penetration, especially in urban areas, will depend primarily on the growth in income levels and the number of working women. Government policies do not have a large bearing on the branded foods industry. Policy changes have, however, largely been supportive to the growth of the sector. The industry was accorded priority status for bank lending in Organised players in the branded foods industry face stiff competition from regional brands. Imported food products are costlier than local equivalents and are, therefore, not competitive in the domestic market. CRISIL COMPANY REPORT 3
4 ANNUAL RESULTS Income Statement Balance sheet (Rs million ) Dec-7 Dec-8 Dec-9 (Rs million ) Dec-7 Dec-8 Dec-9 Net Sales 12,74. 1, ,248.7 Equity share capital Operating Income 13, , ,8.7 Reserves and surplus,947. 7, ,626.6 Tangible net worth 6,367. 7,8.9 9,47.1 EBITDA 2, ,91.2 3,741.3 Deferred tax liablity: asset EBITDA Margin Long-term debt... Short-term-debt... Depreciation Total debt... Interest Current liabilities 2,181. 2,.2 3,89.6 Other Income Total provisions ,294.7 Total liabilities 9,27. 1, ,41.3 PBT 2,41.4 2,84.9 3,64.7 Gross block 4,72.6 4,73. 4,92.6 PAT 1, , ,327.8 Net fixed assets 2, ,21.7 2,318.8 Investments 2, PAT Margin Current assets 3, , ,722. Receivables No. of shares (Mn No.) Inventories 1, , ,66.3 Cash ,79.8 8,198. Earnings per share (EPS) Total assets 9,27. 1, ,41.3 Cash flow Ratio (Rs million ) Dec-7 Dec-8 Dec-9 Dec-7 Dec-8 Dec-9 Pre-tax profit 2, ,9.9 3,611.9 Revenue growth (%) Total tax paid ,64. -1,412.9 EBITDA growth(%) Depreciation PAT growth(%) Change in working capital ,279. EBITDA margins(%) Cash flow from operating activities 2,13.6 1, ,898.2 Tax rate (%) Capital Expenditure PAT margins (%) Investments and others , Dividend payout (%) Cash flow from investing activities -1,7.9 2, Return on Equity (%) Equity raised/(repaid)... Return on capital employed (%) Debt raised/(repaid)... Dividend (incl. tax) Gearing (x)... Others (incl extraordinaries) Interest coverage (x) Debt/EBITDA (x)... Cash flow from financing activities Change in cash position 47. 3, ,488.1 Asset turnover (x) Opening cash ,79.8 Current ratio (x) Closing cash ,79.8 8,198. Gross current assets (days) QUARTERLY RESULTS Profit and loss account (Rs million) Sep-1 % of Rev Sep-9 % of Rev Jun-1 % of Rev Sep-1 % of Rev Sep-9 % of Rev No of Months Revenue 6, , , , , EBITDA 1, , , , Interest Depreciation PBT 1, , , , PAT , , CRISIL COMPANY REPORT 4
5 FOCUS CHARTS & TABLES Rs mn 8, 7, 6,, 4, 3, 2, 1, Dec-7 Mar-8 Sales Quarterly sales & y-o-y growth Jun-8 Sep-8 Dec-8 Mar-9 Jun-9 Sep-9 Dec-9 Mar-1 Jun-1 Sep-1 Sales growth y-o-y (RHS) Rs mn 1,2 1, Dec-7 Mar-8 Quarterly PAT & y-o-y growth Jun-8 Net Profit Sep-8 Dec-8 Mar-9 Jun-9 Sep-9 Dec-9 Mar-1 Jun-1 Sep-1 Net profit growth y-o-y (RHS) Rs/share EPS 3 Movement in operating and net margins Dec-7 Mar-8 Jun-8 Sep-8 Dec-8 Mar-9 Jun-9 Sep-9 Dec-9 Mar-1 Jun-1 Sep-1 Dec-7 Mar-8 Jun-8 OPM Sep-8 Dec-8 Mar-9 Jun-9 Sep-9 Dec-9 Mar-1 NPM Jun-1 Sep-1 Shareholding Pattern () Board of Directors Mar 21 Jun 21 Sep 21 Dec 21 Director Name Promoter Simon James Scarff (Mr.) FII DII Zubair Ahmed (Mr.) Others Subodh K. Bhargava (Mr.) Mukesh Hari Butani (Mr.) Naresh Dayal (Mr.) Designation Non-Executive Chairman, Promoter- Director Managing Director P. Dwarakanath (Mr.) Praveen Kumar Gupta (Mr.) Director Kunal Kashyap (Mr.) Ramakris hnan Subramanian (Mr.) Director Additional Disclosure This report has been sponsored by NSE - Investor Protection Fund Trust (NSEIPFT). Disclaimer This report is based on data publicly available or from sources considered reliable. CRISIL Ltd. (CRISIL) does not represent that it is accurate or complete and hence, it should not be relied upon as such. The data / report is subject to change without any prior notice. Opinions expressed herein are our current opinions as on the date of this report. Nothing in this report constitutes investment, legal, accounting or tax advice or any solicitation, whatsoever. The subscriber / user assume the entire risk of any use made of this data / report. CRISIL especially states that, it has no financial liability whatsoever, to the subscribers / users of this report. This report is for the personal information only of the authorised recipient in India only. This report should not be reproduced or redistributed or communicated directly or indirectly in any form to any other person especially outside India or published or copied in whole or in part, for any purpose. CRISIL is not responsible for any errors and especially states that it has no financial liability whatsoever to the subscribers / users / transmitters / distributors of this report. For information please contact 'Client Servicing' at , or via clientservicing@crisil.com. CRISIL COMPANY REPORT
Hindustan Oil Exploration Co. Ltd
GICS Industry : Oil, Gas & Consumable Fuels l Sub Industry : Oil & Gas Exploration & Production l Website : www.hoec.com Hindustan Oil Exploration Co. Ltd Key Stock Indicators NSE Ticker : HINDOILEXP Bloomberg
More informationOil India Ltd KEY HIGHLIGHTS. Shareholding (As on September 30, 2010) KEY RISKS. Stock Performances vis-à-vis market. Indexed price chart
GICS Industry : Oil, Gas & Consumable Fuels l Sub Industry : Oil & Gas Exploration & Production l Website : www.oil-india.com Oil India Ltd Key Stock Indicators NSE Ticker : OIL Bloomberg Ticker : OINL:IN
More informationOrient Paper & Industries Ltd
GICS Industry : Construction Materials l Sub Industry : Construction Materials l Website : www.orientpaperindia.com Orient Paper & Industries Ltd Key Stock Indicators NSE Ticker : ORIENTPPR Bloomberg Ticker
More informationUco Bank. GICS Industry : Commercial Banks Sub Industry : Diversified Banks Website : Key Stock Indicators
GICS Industry : Commercial Banks Sub Industry : Diversified Banks Website : www.ucobank.com Uco Bank Key Stock Indicators NSE Ticker : UCOBANK CMP as on 11 May 2011 Rs/share : 99.9 Shares outstanding (mn)
More informationGSK Consumer Healthcare Ltd
Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16. Volume No.. I Issue No. 67 GSK Consumer Healthcare Ltd Apr 19 th, 2016 BSE Code: 500676 NSE Code: GSKCONS Reuters
More informationThe Jeypore Sugar Company Ltd
The Jeypore Sugar Company Ltd Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses
More informationReligare Investment Call
v-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 v-18 Q2FY19 Result Update Q2FY19 Result Update BUY CMP (Rs) 5,813 Target Price (Rs) 6,519 Potential Upside 12.1% Sensex
More informationPunjab Chemicals and Crop Protection Ltd
Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis
More informationCompany Overview. Financial Performance
Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 CMP: 32.30 February 11, 2016 Stock Details BSE code 526558 BSE ID JAMEHOT Face value ( ) 10 No of shares (m) 8.0 52 week
More informationCompany Overview. Financial Performance
Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 Feb/16 Mar/16 Monarch Networth Capital Limited CMP: 26.00 March 23, 2016 Stock Details BSE code 511551 BSE ID MONARCH Face value (
More informationThe Jeypore Sugar Company Ltd
Q1FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)
More informationCompany Overview. Financial Performance
Jan/15 Feb/15 Mar/ Apr/15 May/ Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/ Dec/15 Parnax Lab Limited CMP: 53.90 January 08, 2016 Stock Details BSE code 506128 BSE ID PARNAXLAB Face value ( ) 10 No of shares
More informationAarti Industries Ltd KEY HIGHLIGHTS. Shareholding (As on December 31, 2010) KEY RISKS. Indexed price chart. Stock Performances vis-à-vis market
GICS Industry: Chemicals l Sub Industry: Specialty Chemicals l Website : www.aartigroup.com Aarti Industries Ltd Key Stock Indicators NSE Ticker: AARTIIND Bloomberg Ticker: ARTO: IN Face value / Share:
More informationHitech Plast Ltd. Q4FY11 First Cut. Enhancing investment decisions. CRISIL Limited. All Rights Reserved.
Q4FY11 First Cut Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis
More informationSanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart
1QCY2016 Result Update Pharmaceutical May 5, 2016 Sanofi India Performance Highlights Y/E Dec. (` cr) 1QCY2016 4QCY2015 % chg (qoq) 1QCY2015 % chg (yoy) Net sales 506 522 (3.1) 460 10.1 Other income 64
More informationNATCO PHARMA LTD. Result Update (PARENT BASIS): Q1 FY16
ISIN: INE987B01018 OCTOBER 15 th, 2015 STOCK DETAILS Sector NATCO PHARMA LTD. Result Update (PARENT BASIS): Q1 FY16 BSE Code 524816 Face Value 10.00 Pharmaceuticals 52wk. High / Low (Rs.) 2709.00/1245.40
More informationCompany Overview. Industry Overview. Financial Performance
Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 Trade Wings Limited CMP: 105.00 January 29, 2016 Stock Details BSE code 509953 BSE ID TRADWIN Face value ( ) 10 No of
More informationInstitutional Equities
3QFY15 Result Update Institutional Equities GlaxoSmithKline Consumer Healthcare Reuters: GLSM.BO; Bloomberg: SKB IN 4 February 2015 Price Hike Leads To Sales Growth Glaxo SmithKline Consumer Healthcare
More informationGoodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials
1QCY212 Result Update Tyres June 6, 212 Goodyear India Performance Highlights Y/E December (` cr) 1QCY212 1QCY211 % chg (yoy) 4QCY211 % chg (qoq) Net sales 331 336 (1.6) 395 (16.2) EBITDA 2 24 (18.6) 34
More informationGlaxoSmithKline Consumer. Healthcare Ltd Result Update: Q3 CY 11 SYNOPSIS. C.M.P: Rs Target Price: Rs Date: Dec 05 th 2011 BUY
GlaxoSmithKline Consumer Healthcare Ltd Result Update: Q3 CY 11 C.M.P: Rs. 2522.00 Target Price: Rs. 2850.00 Date: Dec 05 th 2011 BUY Stock Data: Sector: Food Processing Face Value Rs. 10.00 52 wk. High/Low
More informationAmber Enterprises India Ltd
3QFY2019 Result Update Consumer Durable February 16, 2019 Amber Enterprises India Ltd Performance Update (` cr) 3QFY19 3QFY18 % yoy 2QFY19 % qoq Revenue 388.8 338.4 14.9 226.3 71.8 EBITDA 22.1 24.1 (8.2)
More informationCompany Overview. Financial Performance
Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 KMC Speciality Hospitals India Ltd CMP: 7.61 January 21, 2015 Stock Details BSE code 524520 BSE ID KMCSHIL Face value
More informationKandagiri Spinning Mills Ltd
Q1FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)
More informationCompany Overview. Industry Overview. Financial Performance
Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 CMP: 27.80 January 20, 2016 Stock Details BSE code 534623 BSE ID JUPITERIN Face value ( ) 10 No of shares (m) 10 52 week
More informationCompany Overview. Financial Performance
Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Superior Industrial Enterprises Limited CMP: 19.6 December 24, 215 Stock Details BSE code 519234 BSE ID SIEL Face value
More informationCompany Overview. Financial Performance
Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Nimbus Projects Limited CMP: 34. December 4, 15 Stock Details BSE code 511714 BSE ID NIMBSPROJ Face value ( ) 1 No of
More informationPlastiblends India Ltd
Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis
More informationQuick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.
Ltd. Creating value through paper Limited (RPL) manufactures writing paper, printing paper and Kraft paper. The company's white writing and printing paper is used in making notebooks and writing material,
More informationeclerx Services Ltd Q3FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved.
Q3FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)
More informationBUY. IFB AGRO INDUSTRIES LTD Result Update (PARENT BASIS): Q1 FY16. CMP Target Price SEPTEMBER 30 th 2015 SYNOPSIS
BUY CMP 382.00 Target Price 440.00 IFB AGRO INDUSTRIES LTD Result Update (PARENT BASIS): Q1 FY16 SEPTEMBER 30 th 2015 ISIN: INE076C01018 Index Details Stock Data Sector Breweries & Distilleries BSE Code
More informationKLRF Ltd. Q3FY11 Result Update. Enhancing investment decisions
Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis
More informationMRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials
Company Update Automobile February 22, 212 MRF Performance Highlights Y/E Sept. (` cr) 1QSY12 1QSY11 % chg (yoy) 4QSY11 % chg (qoq) Net sales 2,875 2,167 32.7 2,62 9.8 EBITDA 258 243 5.9 181 42.6 EBITDA
More informationCCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart
5-Jan 5-Apr 5-Jul 5-Oct 5-Jan 5-Apr 5-Jul 5-Oct 5-Jan 5-Apr 5-Jul 5-Oct CCL Products Brewing Steadily CCL Products Limited (CCL) is the largest Indian manufacturer and exporter of instant coffee. With
More informationITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only
Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18. Volume No.. I Issue No. 186 ITC Ltd September 21, 2018 BSE Code: 500875 NSE Code: ITC Reuters Code: ITC.NS Bloomberg
More informationSanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart
4QCY2016 Result Update Pharmaceutical March 10, 2017 Sanofi India Performance Highlights Y/E Dec. (` cr) 4QCY2016 3QCY2016 % chg (qoq) 4QCY2015 % chg (yoy) Net sales 552 583 (5.3) 522 5.6 Other income
More informationPEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)
BUY CMP 55.30 Target Price 65.00 UMANG DAIRIES LTD Result Update (PARENT BASIS): Q4 FY15 JUNE 17 th 2015 ISIN: INE864B01027 Index Details Stock Data Sector Packaged Foods BSE Code 500231 Face Value 5.00
More informationBlue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.
Aug-15 Oct-15 Dec-15 Feb-16 Apr-16 Jun-16 Aug-16 Oct-16 Dec-16 Jan-17 Apr-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18 May-18 Jul-18 1QFY2019 Result Update Cons. Durable August 10, 2018 Blue Star Ltd Performance
More informationDynamatic Technologies Ltd
Q2FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)
More informationKandagiri Spinning Mills Ltd
Q4FY11 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)
More informationSagar Cements Ltd. Q3FY11 Result Update. Enhancing investment decisions
Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis
More informationLakshmi Finance and Industrial Corporation Ltd
Q1FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)
More informationGarware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months
2QFY217 Result Update Textile November 16, 216 Garware Wall Ropes Performance Highlights Quarterly Data (`cr) 2QFY17 2QFY16 % yoy 1QFY17 % qoq Revenue 232 214 8.5 225 3.3 EBITDA 4 26 5.9 31 29.4 Margin
More informationCompany Overview. Financial Performance
Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 CMP: 31.25 December 24, 2015 Stock Details BSE code 523878 BSE ID TOTEX Face value ( ) 10 No of shares (m) 8.1 Market
More informationAsian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics
3QFY2017 Result Update Ceramics January 25, 2017 Asian Granito Performance Highlights Quarterly Data (` cr) 3QFY17 3QFY16 % yoy 2QFY17 % qoq Revenue 247 236 4.3 265 (7.1) EBITDA 34 27 25.3 31 7.2 Margin
More informationGlaxoSmithKline Pharmaceuticals
3QFY2017 Result Update Pharmaceutical February 15, 2017 GlaxoSmithKline Pharmaceuticals Performance Highlights Y/E Mar (` cr) 3QFY2017 2QFY2017 % chg (QoQ) 3QFY2016 % chg (YoY) NEUTRAL CMP `2,683 Target
More informationBDH Industries Limited BSE Scrip Code:
BDH Industries Limited BSE Scrip Code: 524828 Pharmaceuticals October 23, 2012 Equity Statistics Current Market Price Rs. 16.95 52 Week High/Low Rs. 21.00/13.15 Market Capitalisation Rs. Crores 9.76 Free
More informationAPOLLO TYRES LTD. October 19 th, CMP (Rs.) 194. Key Developments
Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 s. APOLLO TYRES LTD.. October 19 th, 2015 BSE Code: 500877 NSE Code: APOLLOTYRE Reuters Code: APLO.NS Bloomberg
More informationRallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months
Jan-12 Jun-12 Nov-12 Apr-13 Sep-13 Feb-14 Jul-14 Dec-14 May-15 Oct-15 Mar-16 Aug-16 Jan-17 Jun-17 Nov-17 2QFY2018 Result Update Agrichemical November 21, 2017 Rallis India Performance Highlights Y/E March
More informationSiyaram Silk Mills Ltd
Q4FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis
More informationSymphony Ltd. RESULT UPDATE 31st October 2017
. RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential
More informationReligare Investment Call
Q3FY18 Result Update Auto Ancillary BUY CMP (Rs) Target Price (Rs) Potential Upside Sensex Nifty Key Stock data BSE Code NSE Code Bloomberg Shares o/s, Cr (FV 10) Market Cap (Rs Cr) 3M Avg Volume 52 week
More informationShri Lakshmi Cotsyn Ltd
Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis
More informationReligare Investment Call
v-17 v-17 Dec-17 Jan-18 Jan-18 Feb-18 Mar-18 Mar-18 Apr-18 May-18 May-18 Jun-18 Jul-18 Aug-18 Aug-18 Sep-18 Oct-18 Oct-18 Q2FY19 Result Update Q2FY19 Result Update BUY CMP (Rs) 282 Target Price (Rs) 321
More informationCMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212
2QCY17 Result Update July 20, 2017 Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212 Well-placed in Power T&D Hi-tech Space; Order Book Remains Robust India s revenue rose by 6.0% YoY to Rs23.3bn
More informationNestlé India. Q4CY16 Result Update. Healthy Sales growth; higher provisions & CSR impacts bottom-line. Sector: FMCG CMP: ` 6,169. Recommendation: BUY
Nestlé India Q4CY16 Result Update Healthy Sales growth; higher provisions & CSR impacts bottom-line Sector: FMCG CMP: ` 6,169 Recommendation: BUY Market statistics Current stock price (`) 6,169 Shares
More informationPROCTER & GAMBLE HYGIENE & HEALTH CARE LTD Result Update (PARENT BASIS): Q4 FY15
PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD Result Update (PARENT BASIS): Q4 FY15 ISIN: INE179A01014 OCTOBER 5 th 2015 STOCK DETAILS Sector FMCG BSE Code 500459 Face Value 10.00 52wk. High / Low (Rs.) 7435.00/5144.40
More informationMaruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart
Jul-15 Sep-15 Nov-15 Jan-16 Mar-16 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18 May-18 1QFY2019 Result Update Automobile July 27, 2018 Maruti Suzuki India Performance
More informationKLRF Ltd. Q2FY11 Result Update. Enhancing investment decisions
Q2FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis
More informationGAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -
2QFY2013 Result Update Oil & Gas October 26, 2012 GAIL India Performance Highlights Quarterly highlights (Standalone) Y/E March (` cr) 2QFY2013 2QFY2012 % chg (yoy) 1QFY2013 % chg (qoq) Net sales 11,361
More informationNestlé India. Q2CY17 Result Update. Positives priced in; Downgrade to Hold. Sector: FMCG CMP: ` 6,786. Recommendation: HOLD
Nestlé India Q2CY17 Result Update Positives priced in; Downgrade to Hold Sector: FMCG CMP: ` 6,786 Recommendation: HOLD Market statistics Current stock price (`) 6,786 Shares O/S (cr.) 9.6 Mcap (`cr) 65,424
More informationFineotex Chemical Ltd
Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to
More informationCCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.
Feb-15 May-15 Aug-15 Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 3QFY2018 Result Update Coffee February 5, 2018 CCL Products Performance Update Y/E March (` cr) Q3FY18 Q3FY17
More informationBUY. MENON PISTONS LTD Result Update (PARENT BASIS): Q1 FY16 SYNOPSIS. CMP Target Price SEPTEMBER 3 rd, 2015
BUY CMP 151.00 Target Price 174.00 MENON PISTONS LTD Result Update (PARENT BASIS): Q1 FY16 SEPTEMBER 3 rd, 2015 ISIN: INE650G01011 Stock Details Stock Data Sector Auto Parts & Equipment BSE Code 531727
More informationITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months
3QFY2017 Result Update FMCG January 30, 2017 ITC Performance Highlights Quarterly result (Standalone) (` cr) 3QFY17 3QFY16 % yoy 2QFY17 %qoq Revenue 9,248 8,867 4.3 9,661 (4.3) EBITDA 3,546 3,475 2.1 3,630
More informationApollo Hospitals Enterprise Ltd.
Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17. Volume No.. I Issue No. 154 Apollo Hospitals Enterprise Ltd. December 19, 2017 BSE Code: 508869 NSE Code: APOLLOHOSP
More informationACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -
4QCY2012 Result Update Cement February 11, 2013 ACC Performance Highlights Quarterly results (Standalone) Y/E Dec. (` cr) 4QCY2012 3QCY2012 % chg qoq 4QCY2011 % chg yoy Net sales 3,099 2,445 26.8 2,503
More informationLarsen & Toubro Ltd.
Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Volume No.. III Issue No. 163. Larsen & Toubro Ltd. February 26, 2018 BSE Code: 500510 NSE Code: LT Reuters Code:
More informationReligare Investment Call
BUY CMP (Rs) Target Price (Rs) Potential Upside Sensex Nifty Key Stock data BSE Code NSE Code Bloomberg Shares o/s, Cr (FV 1) Market Cap (Rs Cr) 3M Avg Volume 52 week H/L Shareholding Pattern (%) Dec-16
More informationBUY. KDDL LTD Result Update (PARENT BASIS): Q1 FY16 SYNOPSIS. CMP Target Price AUGUST 22 nd 2015 ISIN: INE291D01011
BUY CMP 280.10 Target Price 322.00 KDDL LTD Result Update (PARENT BASIS): Q1 FY16 AUGUST 22 nd 2015 ISIN: INE291D01011 Index Details Stock Data Sector Other Apparels & Accessories BSE Code 532054 Face
More informationCompany Overview. Financial Performance
Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Anisha Impex Ltd CMP: 11.85 December 31, 2015 Stock Details BSE code 537785 BSE ID Face value ( ) 10 No of shares (m)
More informationGraphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods
1QFY2012 Result Update Capital Goods July 25, 2011 Graphite India Performance Highlights Y/E March (` cr) 1QFY2012 4QFY2011 % chg (qoq) 1QFY2011 % chg (yoy) Net sales 319 303 5.1 258 23.3 EBITDA 61 59
More informationBUY SIMPLEX INFRASTRUCTURES LTD SYNOPSIS. CMP Target Price FEBRUARY 28 th Result Update (PARENT BASIS): Q3 FY15
BUY CMP 408.40 Target Price 460.00 SIMPLEX INFRASTRUCTURES LIMITED Result Update (PARENT BASIS): Q3 FY15 FEBRUARY 28 th 2015 ISIN: INE059B01024 Index Details Stock Data Sector Construction & Engineering
More informationThe West Coast Paper Mills Ltd
Q4FY11 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)
More informationReligare Investment Call
BUY CMP (Rs) Target Price (Rs) Potential Upside Sensex Nifty Key Stock data BSE Code NSE Code Bloomberg Shares o/s, Cr (FV 2) Market Cap (Rs Cr) 3M Avg Volume 52 week H/L Shareholding Pattern (%) Promoter
More informationParag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months
2QFY2019 Result Update Dairy Products November 6, 2018 Parag Milk Foods Performance Update Y/E March (` cr) Q2FY19 Q2FY18 % yoy Q1FY19 % qoq Net sales 573 505 13.7% 549 4.4% EBITDA 58 50 16.3% 60-2.7%
More informationHydro S&S Industries Ltd
Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis
More informationNestle India Ltd. RESULT UPDATE
RESULT UPDATE 15th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update Q1CY17 II 15th May, 2017 CMP INR 6819 Target INR 7075 Potential Upside
More informationParag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months
1QFY2019 Result Update Dairy Products August 8, 2018 Parag Milk Foods Performance Update Y/E March (` cr) Q1FY19 Q1FY18 % yoy Q4FY18 % qoq Net sales 549 413 32.9 518 5.9 EBITDA 60 29 103% 55 8.4% EBITDA
More informationWendt (India) Ltd. Q1FY12 Result Update. Enhancing investment decisions. CRISIL Limited. All Rights Reserved.
Q1FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)
More informationABB LTD (INDIA) RESEARCH
RESULTS REVIEW Share Data Market Cap Rs. 168.6 bn Price Rs. 795.80 BSE Sensex 16,741.30 Reuters Bloomberg Avg. Volume (52 Week) ABB.BO ABB IN 0.11 mn 52-Week High/Low Rs. 856.95 / 344 Shares Outstanding
More informationKEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.
May- Aug- Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 4QFY2018 Result Update Cable May 21, 2018 KEI Industries Performance Update Y/E March (` cr) 4QFY18 4QFY17 % yoy 3QFY18
More informationKEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials
3QFY2018 Result Update Cable January 25, 2018 KEI Industries Performance Update Y/E March (` cr) 3QFY18 3QFY17 % yoy 2QFY18 % qoq Net sales 889 715 24 749 19 EBITDA 84 77 10 76 11 EBITDA margin (%) 9.5
More informationReligare Investment Call
Q2FY18 Result Update Auto Ancillary BUY CMP (Rs) Target Price (Rs) Potential Upside Sensex Nifty 144 173 % 33,219 10,303 Operational efficiency to continue ' Revenue (growth not comparable due to change
More informationNestlé India Outlook Hazy; Valuations Prohibitive
Nestlé India Outlook Hazy; Valuations Prohibitive Nestlé India s net sales, EBITDA and net profit surged by 35% yoy, 67% yoy & 116% yoy to Rs23.5bn, Rs4.5bn & Rs2.7bn, respectively in 3QCY16. This growth
More informationThe Varhad Group. Prag Bosimi Synthetics Ltd. Company Overview. FY15 and recent performance CMP: INR5.56. Stock data. Stock performance (%)
Textiles l BSE Research Prag Bosimi Synthetics Ltd. CMP: INR5.56 Stock data BSE code 500192 BSE ID PRAGBOS Face value (INR) 10.0 No of shares (m) 74.4 Market cap (INRm) 413.6 3m avg. daily vol (No) 2,491.6
More informationTimken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy
4QFY16 Result Update Institutional Equities Timken India 23 May 2016 Reuters: TMKN.BO; Bloomberg: TIMK IN Margin Expansion Leads To Huge Growth In Profit; Retain Buy Timken India (TIL), the leading manufacturer
More informationVisaka Industries Ltd
Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%
More informationHOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017
2QCY17 Result Update July 27,2017 Market Cap. (Rs bn) 657 Free Float (%) 37.3 Shares O/S (mn) 96 Good Performance Irrespective of GST Pangs Nestlé India has reported a good set of numbers for 2QCY17 in
More informationBharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1
[ Result Update Equity India Forging & Industrials Bharat Forge Ltd. No Respite in Sight May 29, 2013 CMP (`) Target (`) 241 238 Potential Upside Absolute Rating (1.24)% HOLD Market Info (as on May 28,
More informationMahindra & Mahindra Ltd.
May-15 Aug-15 Nov-15 Feb-16 May-16 Aug-16 Nov-16 Feb-17 May-17 Aug-17 Nov-17 Feb-18 4QFY2018 Result Update Automobile May 30, 2018 Mahindra & Mahindra Ltd. Performance Update Y/E March (` cr) 4QFY18 4QFY17
More informationBlue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.
May-15 Aug-15 Nov-15 Feb-16 May-16 Aug-16 Nov-16 Feb-17 May-17 Aug-17 Nov-17 Feb-18 May-18 4QFY2018 Result Update Cons. Durable May 16, 2018 Blue Star Ltd Performance Update 4QFY18 4QFY17 % chg. (yoy)
More informationMaruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart
Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 2QFY2019 Result Update Automobile November 3, 2018 Maruti Suzuki India Performance Update Y/E March (` cr) 2QFY19
More informationBloomberg Code: ATA IN
Auto OEM: 3-Wheelers Atul Feb Auto 03, 2015 Ltd India Research Stock Broking Bloomberg Code: ATA IN Stable quarter led by surge in exports volumes (TP revised ) : Operating revenue, EBITDA and PAT grew
More informationMaruti Suzuki (RHS) BUY. Operationally In Line; Reiterate Buy. Automobiles October 31, 2014 RESULT REVIEW. Outlook & Valuation.
Oct13 Dec13 Jan14 Feb14 Apr14 May14 Jun14 Aug14 Sep14 Oct14 India Research Automobiles RESULT REVIEW Bloomberg: MSIL IN Reuters: MRTI.BO BUY Operationally In Line; Reiterate Buy India s (MSIL) Revenue/EBIDTA/PAT
More informationGreenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.
Initiating Coverage Plywood March 03, 2018 Greenply Industries The plywood maker for growing India Greenply Industries Ltd (GIL) manufactures plywood & allied products and medium density fibreboards (MDF).
More informationSavera Industries Ltd
Q2FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)
More informationLakshmi Finance and Industrial Corporation Ltd
Q2FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis
More informationRallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart
Jan-12 Jul-12 Jan-13 Jul-13 Jan-14 Jul-14 Jan-15 Jul-15 Jan-16 Jul-16 Jan-17 1QFY2018 Result Update Agrichemical July 26, 2017 Rallis India Performance Highlights Y/E March (` cr) 1QFY2018 4QFY2017 % chg
More informationGMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months
2QFY2019 Result Update Industrial Machinery October 26, 2018 GMM Pfaudler Limited Performance Update Standalone (` cr) Q2FY19 Q2FY18 % yoy Q1FY19 % qoq Net sales 99.2 93.2 29.8% 76.4 6.4% EBITDA 16.0 15.3
More informationMatrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.
4QFY2018 Result Update Cable May 7, 2018 Matrimony.com Ltd Performance Update Y/E March (` cr) 4QFY18 4QFY17 % yoy 3QFY18 % qoq Net sales 84 75 12 84 1 EBITDA 20 11 78 17 15 EBITDA margin (%) 23.6 14.8
More information